No association of CpG island methylator phenotype and colorectal cancer survival: population-based study

The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: a retrospective analysis

(2016) Hae Su Kim et al.   BMC CANCER

Different definitions of CpG island methylator phenotype and outcomes of colorectal cancer: a systematic review

(2016) Min Jia et al.   Clinical Epigenetics

Statin Use and Survival After Colorectal Cancer: The Importance of Comprehensive Confounder Adjustment

(2015) Michael Hoffmeister et al.   JNCI-Journal of the National Cancer Institute

Statin Use and Survival After Colorectal Cancer: The Importance of Comprehensive Confounder Adjustment

(2015) Michael Hoffmeister et al.   JNCI-Journal of the National Cancer Institute

Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis

(2014) Y. Y. Juo et al.   ANNALS OF ONCOLOGY

Stage-specific associations between beta blocker use and prognosis after colorectal cancer

(2014) Lina Jansen et al.   CANCER

Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision

(2013) Marisa Donada et al.   BMC GASTROENTEROLOGY

KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers

(2013) A I Phipps et al.   BRITISH JOURNAL OF CANCER

Toward a comprehensive and systematic methylome signature in colorectal cancers

(2013) Hassan Ashktorab et al.   Epigenetics

Reduced Risk of Colorectal Cancer Up to 10 Years After Screening, Surveillance, or Diagnostic Colonoscopy

(2013) Hermann Brenner et al.   GASTROENTEROLOGY

BRAF Mutation Status and Survival after Colorectal Cancer Diagnosis According to Patient and Tumor Characteristics

(2012) A. I. Phipps et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis

(2012) L. A. Hughes et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer

(2011) Ben Tran et al.   CANCER

Genetics and epigenetics of small bowel adenocarcinoma: the interactions of CIN, MSI and CIMP

(2011) Arne Warth et al.   MODERN PATHOLOGY

The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status

(2010) A. M. Dahlin et al.   CLINICAL CANCER RESEARCH

Microsatellite instability as a marker of prognosis and response to therapy: A meta-analysis of colorectal cancer survival data

(2010) Cecilia Guastadisegni et al.   EUROPEAN JOURNAL OF CANCER

Role of the Serrated Pathway in Colorectal Cancer Pathogenesis

(2010) Barbara Leggett et al.   GASTROENTEROLOGY

5-Fluorouracil Adjuvant Chemotherapy Does Not Increase Survival in Patients With CpG Island Methylator Phenotype Colorectal Cancer

(2010) Rodrigo Jover et al.   GASTROENTEROLOGY

KRAS Mutation and Microsatellite Instability: Two Genetic Markers of Early Tumor Development That Influence the Prognosis of Colorectal Cancer

(2009) Garrett M. Nash et al.   ANNALS OF SURGICAL ONCOLOGY

Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer

(2009) J. A. Sanchez et al.   BRITISH JOURNAL OF SURGERY

Microsatellite instability and survival in rectal cancer

(2009) Wade S. Samowitz et al.   CANCER CAUSES & CONTROL

Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers

(2009) Jung Ho Kim et al.   VIRCHOWS ARCHIV

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

(2008) S. Ogino et al.   GUT

Comprehensive Biostatistical Analysis of CpG Island Methylator Phenotype in Colorectal Cancer Using a Large Population-Based Sample

(2008) Katsuhiko Nosho et al.   PLoS One